-- 
Clal Biotechnology Says Teva Investment in Curetech Completed

-- B y   G w e n   A c k e r m a n
-- 
2011-10-02T09:10:26Z

-- http://www.bloomberg.com/news/2011-10-02/clal-biotechnology-says-teva-investment-in-curetech-completed.html
Clal Biotechnology Industries Ltd. (CBI) 
said that  Teva Pharmaceutical Industries Ltd. (TEVA) â€™s investment in
CureTech Ltd. was completed, leaving Clal with 12 percent of
Curetech. Clal Biotechnology made the announcement to the Tel
Aviv Stock Exchange today.  To contact the reporter on this story:
Gwen Ackerman in Jerusalem at 
 gackerman@bloomberg.net   To contact the editor responsible for this story:
Alisa Odenheimer at 
 aodenheimer@bloomberg.net  